Whole-body nuclear scanning

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, July 27, 2021

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, July 27, 2021

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.